PeptidePedia The community reference

Contributions of ColdChainCleo

User contributions·90 logged edits·page 1 of 1

Contributions by ColdChainCleo, newest first. This list covers edits recorded in the site's change log; the editor's lifetime total of 29,155 edits includes activity predating the current log.

  1. 14:52, 13 Jul 2026 (diff | hist) List of GLP-1 receptor agonists 3,862 ±0 add the glossary entry for the term used in three articles without definition
  2. 19:55, 12 Jul 2026 (diff | hist) Research use only 7,990 ±0 expand §What a business registration does and does not establish
  3. 09:29, 3 Jul 2026 (diff | hist) Talk:Cold chain 1,433 +218 /* Lead is four paragraphs and the fourth is an argument */ reply
  4. 11:10, 23 Jun 2026 (diff | hist) Talk:Customs seizure 674 +112 /* Broken cold chain on detention */ new section
  5. 20:32, 15 Jun 2026 (diff | hist) Third-party testing 7,489 ±0 clarify that a QR code on a certificate proves issuance, not content
  6. 13:15, 1 Jun 2026 (diff | hist) Talk:Chain of custody 885 +124 /* Storage confound */ reply
  7. 02:07, 25 May 2026 (diff | hist) Grey market 4,279 ±0 add the stopper material, since it affects moisture ingress
  8. 14:33, 22 May 2026 (diff | hist) CagriSema 5,687 ±0 m correct the dose ladder — the maintenance dose is not the maximum dose
  9. 17:03, 19 May 2026 (diff | hist) Talk:Cold chain 1,296 +269 /* Domestic refrigerator claim: which studies? */ reply
  10. 04:25, 17 May 2026 (diff | hist) Contraindications of incretin therapy 4,993 ±0 add category for adverse effects
  11. 11:25, 9 May 2026 (diff | hist) Talk:Reconstitution of lyophilised peptides 674 +182 /* Freezing reconstituted solutions */ new section
  12. 15:43, 1 May 2026 (diff | hist) Resin cleavage 4,310 ±0 fix hyphenation per PP:MOS
  13. 23:38, 25 Apr 2026 (diff | hist) Fmoc chemistry 4,618 ±0 m add the light-exposure point for photosensitive material
  14. 09:15, 3 Apr 2026 (diff | hist) Talk:Cold chain 1,581 +348 /* RfC: should this article cover consumer shipping practice? */ reply
  15. 22:18, 30 Mar 2026 (diff | hist) Temperature excursion 24,964 +325 correct the humidity figure — relative humidity needs its temperature
  16. 00:29, 19 Mar 2026 (diff | hist) Loss on drying 4,874 ±0 m add the cross-link to the compendial chapter
  17. 01:50, 18 Mar 2026 (diff | hist) Fasting insulin 4,198 ±0 add the biological variation figure with its citation
  18. 16:04, 10 Mar 2026 (diff | hist) Talk:Temperature excursion 1,022 +340 /* Should freezing be a separate article? */ reply
  19. 14:52, 2 Mar 2026 (diff | hist) Talk:Lyophilisation 1,159 +326 /* Worked sublimation example: single vial or batch? */ reply
  20. 16:55, 20 Feb 2026 (diff | hist) Regulatory status by jurisdiction 4,444 ±0 attribute the enforcement statement to the published policy
  21. 22:37, 15 Feb 2026 (diff | hist) Amino acid analysis 4,943 ±0 m add the note on co-elution and what it hides
  22. 09:45, 28 Jan 2026 (diff | hist) Talk:Cold-chain freight 400 +192 /* A cold pack is not evidence */ new section
  23. 18:27, 27 Jan 2026 (diff | hist) Global access disparity 4,391 ±0 correct the deductible description
  24. 07:52, 27 Jan 2026 (diff | hist) Glucagon 7,074 ±0 add the structural figure and caption it properly
  25. 19:07, 19 Jan 2026 (diff | hist) Underfilling 4,882 ±0 rm the ranking language; this wiki publishes no ranking
  26. 21:58, 17 Jan 2026 (diff | hist) Syringe dead space 18,162 +1,613 add the sharps-disposal cross-link
  27. 08:28, 8 Jan 2026 (diff | hist) Sterile water for injection 4,738 ±0 add the preservative point: unpreserved diluent changes the interval
  28. 14:47, 27 Dec 2025 (diff | hist) Chinese Peptide Company 15,513 ±0 expand §Ordering and availability
  29. 05:49, 18 Dec 2025 (diff | hist) Repackaging 4,759 ±0 m correct the eutectic temperature — source gives a range
  30. 05:44, 6 Dec 2025 (diff | hist) Blind sampling 8,193 ±0 m add short description
  31. 09:11, 5 Dec 2025 (diff | hist) Talk:Peptide stability table 959 +95 /* Should extrapolated rows be in the table at all? */ reply
  32. 19:23, 29 Nov 2025 (diff | hist) Body composition assessment 5,029 ±0 correct the decimal place in the conversion factor
  33. 18:11, 15 Nov 2025 (diff | hist) Preparative HPLC purification 4,882 ±0 correct the transit-time figure — the source gives a median, not a maximum
  34. 15:37, 7 Nov 2025 (diff | hist) C-peptide 4,400 ±0 m state whether the figure is a mean or a median
  35. 09:26, 30 Oct 2025 (diff | hist) Peptide 6,813 ±0 m consistent en dashes in ranges
  36. 02:17, 26 Oct 2025 (diff | hist) Syringe dead space 9,004 +393 fix indentation in the source
  37. 02:10, 12 Oct 2025 (diff | hist) Repackaging 4,759 ±0 m expand §Repackaging as a market structure
  38. 02:29, 11 Oct 2025 (diff | hist) Mass spectrometry 5,612 ±0 add the reference standard and its traceability
  39. 10:51, 8 Oct 2025 (diff | hist) Talk:Cold chain 1,444 +60 /* The freezing claim needs the review, not the press coverage */ reply
  40. 06:47, 5 Oct 2025 (diff | hist) Global access disparity 4,391 +116 m add category for pricing
  41. 06:38, 13 Sep 2025 (diff | hist) Resin cleavage 4,310 +281 m expand §Cocktails and scavengers
  42. 13:39, 8 Sep 2025 (diff | hist) Talk:Peptide stability table 611 +232 /* Sourcing of the reconstituted-stability column */ reply
  43. 16:52, 27 Aug 2025 (diff | hist) Talk:Temperature excursion 748 +325 /* In-use allowance table: which jurisdiction? */ reply
  44. 05:24, 7 Aug 2025 (diff | hist) Glucose-dependent insulinotropic polypeptide 8,265 +427 give the magnitude of the incretin effect as a percentage of the insulin response
  45. 14:02, 6 Aug 2025 (diff | hist) Talk:Tianjin Finder Chemical 748 +193 /* Certificate date and dispatch date */ reply
  46. 06:29, 6 Aug 2025 (diff | hist) VendorInvestigate 5,067 ±0 expand §What it cannot establish
  47. 16:12, 22 Jul 2025 (diff | hist) Talk:Cold chain 885 +297 /* Logger accuracy: is ±0.5 °C a standard or an expectation? */ reply
  48. 10:55, 17 Jul 2025 (diff | hist) Talk:Nantong Guangyuan Chemical 1,170 +135 /* The warehouse interval is a fact a purchaser can ask for */ reply
  49. 09:26, 15 Jul 2025 (diff | hist) Talk:Nantong Guangyuan Chemical 537 +272 /* The warehouse interval is a fact a purchaser can ask for */ new section
  50. 05:42, 11 Jul 2025 (diff | hist) Glucose-dependent insulinotropic polypeptide 7,838 +940 de-duplicate a repeated sentence
  51. 00:14, 26 Jun 2025 (diff | hist) Personal importation policy 3,773 +522 m add the jurisdiction to the legal statement
  52. 03:14, 19 Jun 2025 (diff | hist) Area percent purity 6,764 +166 correct the flow rate — the source gives it in mL/min
  53. 08:41, 12 Jun 2025 (diff | hist) Talk:Temperature excursion 822 +186 /* Worked MKT example: check of the arithmetic */ reply
  54. 22:00, 10 Jun 2025 (diff | hist) Zhuhai Kerui Biotechnology 2,751 +234 add the reception tally with its period and count stated
  55. 08:20, 27 May 2025 (diff | hist) Peptide 6,609 +899 m add the collapse-temperature point, sourced
  56. 11:55, 23 May 2025 (diff | hist) Crude peptide 3,938 +22 the article confused primary and secondary drying; corrected
  57. 15:44, 14 May 2025 (diff | hist) Talk:Flourishglobal Peptide Biotech 748 +235 /* State the packing, do not explain it */ reply
  58. 20:51, 7 May 2025 (diff | hist) Tianjin Finder Chemical 8,089 +456 clarify that a registered business scope is a licensing fact, not a quality assurance
  59. 16:44, 6 May 2025 (diff | hist) Talk:Lyophilisation 748 +252 /* Vapour-pressure table: source and rounding */ reply
  60. 14:10, 1 May 2025 (diff | hist) Injection site rotation 4,064 ±0 m add the sharps-disposal cross-link
  61. 15:26, 25 Apr 2025 (diff | hist) Medutest 3,795 ±0 ce
  62. 14:03, 8 Apr 2025 (diff | hist) Talk:Cold chain 748 +362 /* Mean kinetic temperature: the worked example */ reply
  63. 13:53, 5 Apr 2025 (diff | hist) Custom peptide synthesis 3,777 ±0 m add the note that lyophilised material tolerates excursions better than solution
  64. 11:07, 20 Mar 2025 (diff | hist) Talk:Vial 1,033 +237 /* Merge proposal: Multi-dose vial into this article */ reply
  65. 21:46, 19 Mar 2025 (diff | hist) Sangon Biotech 6,767 +822 m clarify that a registered business scope is a licensing fact, not a quality assurance
  66. 12:37, 17 Mar 2025 (diff | hist) Crude peptide 3,916 +265 m expand §What is in it
  67. 20:54, 15 Mar 2025 (diff | hist) Resin cleavage 3,277 ±0 ce per PP:MOS
  68. 08:35, 12 Mar 2025 (diff | hist) Talk:Peptide supply chain 959 +116 /* Repackaging: how common is it really? */ reply
  69. 03:44, 28 Feb 2025 (diff | hist) Glossary of peptide terminology 3,581 ±0 de-orphan
  70. 09:36, 10 Jan 2025 (diff | hist) Peptide supply chain 4,143 +131 ce, tighten prose
  71. 04:50, 26 Dec 2024 (diff | hist) Dipeptidyl peptidase-4 4,907 +571 m expand §Catalytic action and substrate range
  72. 04:46, 11 Dec 2024 (diff | hist) Grey market 1,800 ±0 expand §How goods leave authorised channels
  73. 06:13, 3 Dec 2024 (diff | hist) Triple agonist 2,546 ±0 m rm duplicated pharmacokinetics — the same figures appear in the infobox
  74. 00:27, 19 Nov 2024 (diff | hist) Resin cleavage 2,920 +557 correct the eutectic temperature — source gives a range
  75. 09:36, 18 Nov 2024 (diff | hist) Peptide synthesis 3,621 +583 rm the vendor-specific packaging detail; not general enough for the article
  76. 23:35, 15 Nov 2024 (diff | hist) Semaglutide 6,658 +1,050 expand §Chemistry and engineering
  77. 14:41, 5 Nov 2024 (diff | hist) Talk:Peptide supply chain 611 +222 /* The empty cell in the last row of the table */ reply
  78. 05:28, 18 Oct 2024 (diff | hist) Liraglutide 3,239 ±0 add short description
  79. 00:25, 8 Oct 2024 (diff | hist) Lixisenatide 1,190 +1,190 N start article on the compound
  80. 11:16, 24 Sep 2024 (diff | hist) Batch number 2,494 +33 fix the anchor on an internal link
  81. 01:25, 17 Sep 2024 (diff | hist) Reference standard 2,872 ±0 m ce
  82. 20:48, 16 Sep 2024 (diff | hist) Lyophilisation 4,024 ±0 rm a duplicated category
  83. 17:31, 2 Sep 2024 (diff | hist) Dipeptidyl peptidase-4 3,295 ±0 m add the citation for the co-secretion finding
  84. 08:47, 14 Aug 2024 (diff | hist) Talk:Cold chain 1,033 +60 /* Storage definitions: table or prose? */ reply
  85. 10:05, 12 Aug 2024 (diff | hist) Talk:Cold chain 400 +341 /* Storage definitions: table or prose? */ new section
  86. 14:16, 3 Aug 2024 (diff | hist) Incretin effect 3,698 +1,345 add the counter-regulatory glucagon point, sourced
  87. 12:32, 20 Jul 2024 (diff | hist) Proglucagon 1,868 ±0 space between number and unit per PP:MOS
  88. 22:15, 7 Jul 2024 (diff | hist) GL Biochem (Shanghai) 2,837 +1,033 add the research-use-only statement to the lead rather than only the footer
  89. 00:58, 5 Jul 2024 (diff | hist) STEP trial programme 2,343 +1,044 de-duplicate a repeated sentence
  90. 12:52, 4 Jul 2024 (diff | hist) Karl Fischer titration 1,651 +1,651 N start article on the analytical method